Chardan Capital Markets analyst Keay Nakae initiates coverage on Chardan Healthcare Acquisition Corp. (NYSE: CHAC) with a Buy rating and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE